UHPLC/ESI-Q-TOF-MS method for the measurement of dopamine in rodent striatal tissue: A comparative effects of intranasal administration of ropinirole solution over nanoemulsion

Drug Testing and Analysis

Volumn 5, Issue 8, 2013, Pages 702-709

  Mustafa, Gulam ^a   Ahmad, Niyaz ^a   Baboota, Sanjula ^a   Ali, Javed ^a   Ahuja, Alka ^a,b  

^a HAMDARD UNIVERSITY   (India)

^b OMAN MEDICAL COLLEGE   (Oman)

Author keywords

Dopamine; ex vivo stability; Matrix effect; Parkinson's disease; Ruggedness; UHPLC ESI Q TOF MS; Validation

Indexed keywords

AMINES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROPHYSIOLOGY; RATS; SOLVENT EXTRACTION;

DOPAMINE; EX VIVO STABILITY; EX-VIVO; MATRICES EFFECT; PARKINSON'S DISEASE; RATS BRAIN; RUGGEDNESS; UHPLC/ESI-Q-TOF-MS; VALIDATION; WISTAR RAT;

ELECTROSPRAY IONIZATION;

ACETIC ACID ETHYL ESTER; ACETONITRILE; DOPAMINE; FORMIC ACID; ROPINIROLE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; EXPERIMENTAL RAT; FREEZE THAWING; IN VIVO STUDY; LIMIT OF DETECTION; LIQUID LIQUID EXTRACTION; MALE; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; ROOM TEMPERATURE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

DOPAMINE; EX VIVO STABILITY; MATRIX EFFECT; PARKINSON'S DISEASE; RUGGEDNESS; UHPLC/ESI-Q-TOF-MS; VALIDATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; INDOLES; LIMIT OF DETECTION; MALE; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84882243842     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1426     Document Type: Article

References (22)

1. H. K. Yildrim, A. Uren, U. Yucel . Evaluation of biogenic amines in organic and non- organic wines by HPLC-OPA determination. Food Technol. Biotech. 2007, 45, 62.
2. M. V. Ugryumov . The differentiation of dopaminergic neurons in situ, in vivo, and in transplants. Neurosci. Behav. Physiol. 2000, 30, 37.
3. W. C. Koller, M. G. Rueda . Mechanism of action of dopaminergic agents in Parkinson's disease. Neurology 1998, 50, 11.
4. N. D. Volkow, J. S. Fowler, G. J. Wang, J. M. Swanson, F. Telang . Dopamine in drug abuse and addiction: Results of imaging studies and treatment implications. Arch. Neurol. 2007, 64, 1575.
5. H. X. Zhao, H. Mu, Y. H. Bai, H. Yu, Y. M. Hu . A rapid method for the determination of dopamine in porcine muscle by pre-column derivatization and HPLC with fluorescence detection. J. Pharmaceut. Anal. 2011, 1, 208.
6. G. L. Diggory, W. R. Buckett . An automated method to measure monoamines and metabolites using elevated temperature reversed phase HPLC with electrochemical detection: Application to striatal dopamine and hippocampal serotonin turnover. J. Pharmacol. Method. 1984, 11, 207.
7. C. Muzzi, E. Bertocci, L. Terzuoli, B. Porcelli, I. Ciari, R. Pagani, et al. Simultaneous determination of serum concentrations of levodopa, dopamine, 3-O-methyldopa and α-methyldopa by HPLC. Biomed. Pharmacother. 2008, 62, 253.
8. M. Karimi, J. L. Carl, S. Loftin, J. S. Perlmutter . Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3, 4-dihydroxyphenyl acetic acid. J. Chromatogr. B 2006, 836, 120.
9. H. C. Ben, J. C. V. Westerink . Evaluation of the effect of drugs on dopamine metabolism in the rat superior cervical ganglion by HPLC with electrochemical detection. Eur. J. Pharmacol. 1980, 65, 71.
10. G. Cannazza, A. D. Stefano, B. Mosciatti, D. Braghiroli, M. Baraldi, F. Pinnen, et al. Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC. J. Pharmaceut. Biomed. 2005, 36, 1079.
11. C. D. Kilts, C. M. Anderson . The simultaneous quantification of dopamine, norepinephrine and epinephrine in micropunched rat brain nuclei by on-line trace enrichment HPLC with electrochemical detection: Distribution of catecholamines in the limbic system. Neurochem. Int. 1986, 9, 437.
12. M. R. Holdiness, M. T. Rosen, J. B. Justice, D. B. Neill . Gas chromatographic-mass spectrometric determination of dopamine in subregions of rat brain. J. Chromatogr. A 1980, 198, 329.
13. V. Carrera, E. Sabater, E. Vilanova, M. A. Sogorb . A simple and rapid HPLC-MS method for the simultaneous determination of epinephrine, norepinephrine, dopamine and 5-hydroxytryptamine: Application to the secretion of bovine chromaffin cell cultures. J. Chromatogr. B 2007, 847, 88.
14. A. El-Beqqali, A. Kussak, M. Abdel-Rehim . Determination of dopamine and serotonin in human urine samples utilizing microextraction online with liquid chromatography/electrospray tandem mass spectrometry. J. Sep. Sci. 2007, 30, 421.
15. H. Y. Wang, Y. Sun, B. Tang . Study on fluorescence property of dopamine and determination of dopamine by fluorimetry. Talanta 2002, 57, 899.
16. H. Koa, R. A. Lahtia, D. J. Duchampa, M. E. Royera, M. Ihnata, R. J. Westerbya . A GC-MS Procedure for the measurement of dopamine in mouse striatal tissue. Anal. Lett. 1974, 7, 243.
17. C. A. Heidbreder, L. Lacroix, A. R. Atkins, A. J. Organ, S. Murray, A. West, et al. Development and application of a sensitive high performance ion-exchange chromatography method for the simultaneous measurement of dopamine, 5-hydroxytryptamine and norepinephrine in microdialysates from the rat brain. J. Neurosci. Method. 2001, 112, 135.
18. M. Moriarty, A. Lee, B. O'Connell, A. Kelleher, H. Keeley, A. Furey . Development of an LC-MS/MS method for the analysis of serotonin and related compounds in urine and the identification of a potential biomarker for attention deficit hyperactivity/hyperkinetic disorder. Anal. Bioanal. Chem. 2011, DOI: 10.1007/s00216-011-5322-7
19. L. Novakov, L. Matysov, P. Solich . Advantages of application of UPLC in pharmaceutical analysis. Talanta 2006, 68, 908.
20. R. Plumb, J. Castro-Perez, J. Gragner, I. Beattie, K. Joncour, A. Wright . Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2004, 19, 2331.
21. FDA. Guidance for Industry Bioanalytical Method Validation. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf [18 February 2012].
22. L. C. Dickson, J. D. MacNeil, S. Lee, A. C. Fesser . Determination of beta-agonist residues in bovine urine using liquid chromatography-tandem mass spectrometry. J. AOAC Int. 2005, 88, 46.